Yew Bio-Pharm Group (YEWB) Short Interest Ratio & Short Volume → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free YEWB Stock Alerts $0.0002 0.00 (0.00%) (As of 11/8/2023) Add Compare Share Share Short InterestStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Yew Bio-Pharm Group Short Interest DataCurrent Short Volume5,000 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$197.50Short Interest Ratio / Days to Cover8.3Last Record DateJuly 15, 2022Today's Trading Volume0 sharesAverage Trading Volume0 sharesToday's Volume Vs. AverageNaN Short Selling Yew Bio-Pharm Group ? Sign up to receive the latest short interest report for Yew Bio-Pharm Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatYEWB Short Interest Over TimeYEWB Days to Cover Over TimeYEWB Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Yew Bio-Pharm Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20225,000 shares $197.50 No ChangeN/A8.3 $0.04 9/15/2021100 shares $10.00 No ChangeN/A1 $0.10 6/15/2021100 shares $18.00 No ChangeN/A0 $0.18 4/15/2021300 shares $47.22 +200.0%N/A0.2 $0.16 3/31/2021100 shares $17.25 No ChangeN/A0 $0.17 2/12/20215,000 shares $749.50 No ChangeN/A2 $0.15 1/29/20215,000 shares $440.80 No ChangeN/A50 $0.09 12/31/20201,000 shares $110.00 No ChangeN/A0.2 $0.11 3/13/2020100 shares $12.00 No ChangeN/A0.1 $0.12 YEWB Short Interest - Frequently Asked Questions What is Yew Bio-Pharm Group's current short interest? Short interest is the volume of Yew Bio-Pharm Group shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 5,000 shares of YEWB short. Learn More on Yew Bio-Pharm Group's current short interest. What is a good short interest ratio for Yew Bio-Pharm Group? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. YEWB shares currently have a short interest ratio of 8.0. Learn More on Yew Bio-Pharm Group's short interest ratio. Is Yew Bio-Pharm Group's short interest increasing or decreasing? Yew Bio-Pharm Group saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 5,000 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Yew Bio-Pharm Group's short interest compare to its competitors? Here is how the short interest of companies in the sector of "consumer staples" compare to Yew Bio-Pharm Group: CHS Inc. (0.15%), Coca-Cola FEMSA, S.A.B. de C.V. (0.67%), Coffee Holding Co., Inc. (0.15%), Fomento Económico Mexicano, S.A.B. de C.V. (0.87%), JRjr33, Inc. (0.02%), Mastery Education (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.50 billion), KLA Co. ($2.53 billion), Lucid Group, Inc. ($2.50 billion), T. Rowe Price Group, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.78 billion), Coinbase Global, Inc. ($1.78 billion), HP Inc. ($1.75 billion), Rivian Automotive, Inc. ($1.70 billion), Lumen Technologies, Inc. ($1.58 billion), and Chesapeake Energy Co. ($1.45 billion). View all of the most shorted stocks. What does it mean to sell short Yew Bio-Pharm Group stock? Short selling YEWB is an investing strategy that aims to generate trading profit from Yew Bio-Pharm Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Yew Bio-Pharm Group? A short squeeze for Yew Bio-Pharm Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of YEWB, which in turn drives the price of the stock up even further. How often is Yew Bio-Pharm Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including YEWB, twice per month. The most recent reporting period available is July, 15 2022. More Short Interest Resources from MarketBeat Related Companies: CAWW Short Interest CHSCP Short Interest KOF Short Interest JVA Short Interest FMX Short Interest HEINY Short Interest JAPAY Short Interest JRJRQ Short Interest KNBWY Short Interest PEDH Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:YEWB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe AI stock to buy right nowStockEarnings